Newmark Issues Unsecured Debt to Pay Off Outstanding Loans

Newmark Group, Inc. (NASDAQ: NMRK) has announced its intention to commence an offering of senior unsecured notes, subject to market conditions and other factors. The company stated that the notes are to be offered and sold in a private offering exempt from the registration requirements under the securities act of 1933.

According to data, Newmark Group's stock moved -1.4% to close out the week, and is currently trading at a price of $10.13 per share.

In response to the announcement, company management provided insight into their plans, stating, "The company intends to use the net proceeds to repay all or a portion of the $420.0 million outstanding under its term loan. Any additional net proceeds will be used to repay outstanding revolving debt, including with respect to the borrowings under the company's credit agreement with Cantor Fitzgerald, L.P., and for general corporate purposes."

The full 8-K submission can be accessed here.

2018 2019 2020 2021 2022 2023
Revenue (MM) $2,048 $2,218 $1,905 $2,906 $2,706 $2,330
Revenue Growth n/a 8.33% -14.12% 52.57% -6.91% -13.87%
Interest Income (MM) -$50 -$32 -$38 -$33 -$31 -$32
Operating Margins 16% 11% 10% 43% 7% 3%
Net Margins 5% 5% 4% 26% 3% 1%
Net Income (MM) $107 $117 $80 $751 $83 $12
Depreciation & Amort. (MM) $98 $131 $141 $122 $166 $169
Earnings Per Share $0.64 $0.58 $0.39 $3.8 $0.45 $0.08
Diluted Shares (MM) 164 185 180 196 245 247
Free Cash Flow (MM) -$353 $952 -$797 -$68 $1,134 $380
Capital Expenditures (MM) $21 $35 $20 $20 $62 $66
Current Ratio 1.06 1.03 1.07 1.15 0.68 0.93

Newmark has growing revenues and increasing reinvestment in the business, low leverage, and irregular cash flows. However, the firm has declining EPS growth. Finally, we note that Newmark has average net margins with a negative growth trend.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS